MEDICINE DETAILS
Reblozyl
Active ingredient: Luspatercept
Reblozyl is recorded in this directory with the active ingredient Luspatercept. This page brings together catalogue strength, dosage-form and pack records so they can be checked against a prescription.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Reblozyl used for?
Reblozyl (luspatercept) is an interleukin-23 (IL-23) inhibitor used for the treatment of anemia (low red blood cells) in adults with:
- Transfusion-dependent anemia (low red blood cells) associated with beta thalassemia.
- Myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).
It is not for use as a substitute for red blood cell transfusions in people who need immediate treatment for anemia.
It is available in vial form for under-the-skin injections.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Reblozyl identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
25 mg · 1 vial Catalogue organisation: Bristol-Myers Squibb GmbH & Co. KGaA
-
75 mg · 1 vial Catalogue organisation: Bristol-Myers Squibb GmbH & Co. KGaA
OFFICIAL SOURCES
Check the Reblozyl record at an official source.
Search for “Reblozyl” or “Luspatercept”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Reblozyl.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Reblozyl
01What is Reblozyl?＋
This directory record associates the brand name Reblozyl with the active ingredient Luspatercept. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Reblozyl strengths and packs are recorded?＋
The catalogue currently shows: 25 mg · 1 vial; 75 mg · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Reblozyl?＋
Catalogue records currently name: Bristol-Myers Squibb GmbH & Co. KGaA. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Reblozyl?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Reblozyl, payment request, stock guarantee or binding offer.
06Can I buy Reblozyl from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.